Related Experiment Video
Updated: May 27, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Testosterone and cardiovascular risk in patients with erectile dysfunction
G Corona1, G Rastrelli, G Balercia
1Sexual Medicine and Andrology and Unit, Department of Clinical Physiopathology, University of Florence, Italy.
Low testosterone levels are linked to cardiovascular disease risk in men with erectile dysfunction. This association is significant in non-obese individuals, suggesting obesity may mask the direct impact of testosterone on heart health.
Area of Science:
- Endocrinology
- Cardiology
- Men's Health
Background:
- The link between cardiovascular diseases (CVD) and testosterone (T) levels in men requires further clarification.
- Erectile dysfunction (ED) is often associated with underlying cardiovascular risk factors.
Purpose of the Study:
- To investigate the association between testosterone levels and cardiovascular risk in men with ED.
- To determine if body mass index (BMI) confounds the relationship between testosterone and cardiovascular risk stratification.
Main Methods:
- Analysis of 2269 male patients with ED.
- Cardiovascular risk assessment using the Progetto Cuore risk engine.
- Evaluation of testosterone levels (total, free, SHBG-bound, and unbound) in relation to cardiovascular risk and BMI.
Main Results:
- Testosterone levels (SHBG-bound and unbound) decreased with increasing cardiovascular risk, even after adjusting for BMI and comorbidities.
- Higher prevalence of hypogonadism symptoms correlated with increased cardiovascular risk.
- Age, cholesterol levels, and diabetes were associated with cardiovascular risk-dependent changes in testosterone levels.
- The observed associations between testosterone and cardiovascular risk were significant only in non-obese patients (BMI < 30 kg/m²).
Conclusions:
- Hypogonadism may be linked to either increased or decreased cardiovascular risk, depending on individual patient characteristics.
- Low testosterone in obese patients might be a consequence of higher cardiovascular risk rather than a direct cause.
Related Concept Videos
Disorders of the Male Reproductive System
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra. Symptoms...
Assessment of the Cardiovascular System I: Subjective Data
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Coronary Artery Disease I: Introduction
Atherosclerosis III: Management
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...